10 January 2014 - Plans for NICE to take into account the benefit to wider society of new drugs licensed for use on the NHS could result in elderly patients missing out on new treatments, the Daily Telegraph has reported.
The paper reports that changes to NICE's existing appraisal system will see the Institute evolve its current methods to also take account of the wider societal benefits alongside the cost and clinical benefits of a medication.
The Telegraph then wrongly speculates that this will result in older patients missing out on treatments because they do not contribute as much to society as younger people.

For more details, go to: http://www.nice.org.uk/newsroom/features/WillElderlyPatientsMissOutOnNewDrugs.jsp